This article has Open Peer Review reports available.
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
- Chunlei Ge†1,
- Ruilei Li†1,
- Haifeng Song†1,
- Tao Geng1,
- Jinyan Yang1,
- Qinghua Tan1,
- Linfeng Song1,
- Ying Wang1,
- Yuanbo Xue1,
- Zhen Li1,
- Suwei Dong1,
- Zhiwei Zhang1,
- Na Zhang1,
- Jiyin Guo1,
- Lin Hua1,
- Siyi Chen2, 3, 4Email author and
- Xin Song1Email author
© The Author(s). 2017
Received: 15 July 2016
Accepted: 29 November 2017
Published: 21 December 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|15 Jul 2016||Submitted||Original manuscript|
|8 Feb 2017||Reviewed||Reviewer Report - Abhishek Garg|
|14 Feb 2017||Reviewed||Reviewer Report - Shigetaka Shimodaira|
|18 Feb 2017||Reviewed||Reviewer Report - Tuncay Göksel|
|24 Jul 2017||Author responded||Author comments - Chunlei Ge|
|Resubmission - Version 2|
|24 Jul 2017||Submitted||Manuscript version 2|
|28 Jul 2017||Reviewed||Reviewer Report - Abhishek Garg|
|29 Nov 2017||Author responded||Author comments - Chunlei Ge|
|Resubmission - Version 3|
|29 Nov 2017||Submitted||Manuscript version 3|
|29 Nov 2017||Editorially accepted|
|21 Dec 2017||Article published||10.1186/s12885-017-3859-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.